ANRO · Alto Neuroscience, Inc.
30.27
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$1.19B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 18/09/2026 04:10:00 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Engulfing Bearish
- Engulfing Bearish (Realtime)
- HALO All
- HALO Momentum
Key Fundamentals
EPS 3 yr Growth
102.30%
EBITDA Margin
N/A
Operating Cashflow
-$52m
Free Cash Flow Return
-30.40%
ROIC
-37.10%
Interest Coverage
-26.60
Quick Ratio
15.70
Performance
52 weeks range
Low 3.59 - 37.48
Trade Value (12mth)
US$2,749,542.00
1 week
-2.21%
1 month
-11.21%
YTD
86.74%
1 year
653.77%
All time high
37.48
Additional Data
Shares Outstanding (Fully Diluted)
43m
HALO Sector
Healthcare
Next Company Report Date
24-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Strong
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
28 August 26EDG | |
13 August 26EDG | |
13 August 26EDG | |
13 August 26EDG | |
14 July 26EDG |
Key Stakeholders
| Name | Title |
| Vivo Capital LLC | Private Company |
| Amit Etkin | Individual |
| Christopher Nixon Cox | Individual |
| Venrock Associates | Private Company |
| OrbiMed Advisors Private Equity | Subsidiary |
